Cohance Lifesciences

quarterly
yearly
ParticularsDec '24Mar '25Jun '25Sep '25Dec '25
Revenue697.79852.47563.48571.17550.71
Expenses493.22675.82492.62487.40505.25
EBITDA258.93241.27126.18136.55101.51
EBIT215.37171.3272.9492.5349.71
Profit Before Tax204.57160.8762.7683.7740.60
Net Profit153.48117.1546.4066.3929.02
Financial Ratios
Operating Profit Margin38.29%26.83%21.50%24.58%17.75%
Net Profit Margin22.64%15.70%9.95%13.33%7.36%
Earning Per Share (Diluted)4.013.101.271.930.96
Dividends Per Share0.000.000.000.000.00